Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts
Authors
Keywords
Non-small cell lung cancer, Histology, Carcinomas, Carcinoma cells, Squamous cell carcinomas, Biomarkers, Cancer treatment, MicroRNAs
Journal
PLoS One
Volume 13, Issue 3, Pages e0194609
Publisher
Public Library of Science (PLoS)
Online
2018-03-23
DOI
10.1371/journal.pone.0194609
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non–Small-Cell Lung Cancer: A Competing Risks Analysis
- (2017) Takashi Eguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer
- (2017) Kira Philipsen Prahm et al. PLoS One
- Abstract CT154: Phase I dose-escalating PoC study to evaluate the safety and tolerability of LiPlaCis (liposomal cisplatin formulation) in patients with advanced or refractory tumors
- (2016) Ulrik Lassen et al. CANCER RESEARCH
- SFPQ•NONO and XLF function separately and together to promote DNA double-strand break repair via canonical nonhomologous end joining
- (2016) Lahcen Jaafar et al. NUCLEIC ACIDS RESEARCH
- g:Profiler—a web server for functional interpretation of gene lists (2016 update)
- (2016) Jüri Reimand et al. NUCLEIC ACIDS RESEARCH
- Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data
- (2016) Ida Kappel Buhl et al. PLoS One
- 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
- (2015) W. E. E. Eberhardt et al. ANNALS OF ONCOLOGY
- A Proteomic Strategy Identifies Lysine Methylation of Splicing Factor snRNP70 by the SETMAR Enzyme
- (2015) Scott M. Carlson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- DNA repair mechanisms in cancer development and therapy
- (2015) Alessandro Torgovnick et al. Frontiers in Genetics
- ANP32E is a histone chaperone that removes H2A.Z from chromatin
- (2014) Arnaud Obri et al. NATURE
- Development and Validation of a Gene Expression Score That Predicts Response to Fulvestrant in Breast Cancer Patients
- (2014) Steen Knudsen et al. PLoS One
- The RNA-Binding Protein QKI Suppresses Cancer-Associated Aberrant Splicing
- (2014) Feng-Yang Zong et al. PLoS Genetics
- Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma
- (2013) I. I. Wistuba et al. CLINICAL CANCER RESEARCH
- Keratin 8 and 18 Loss in Epithelial Cancer Cells Increases Collective Cell Migration and Cisplatin Sensitivity through Claudin1 Up-regulation
- (2013) Anne-Marie Fortier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Independent Validation of a Model Using Cell Line Chemosensitivity to Predict Response to Therapy
- (2013) Wenting Wang et al. JNCI-Journal of the National Cancer Institute
- Detection of Impaired Homologous Recombination Repair in NSCLC Cells and Tissues
- (2013) Moritz Birkelbach et al. Journal of Thoracic Oncology
- Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer
- (2012) Ryan K Van Laar BMC Medical Genomics
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Complex Cisplatin-Double Strand Break (DSB) Lesions Directly Impair Cellular Non-Homologous End-Joining (NHEJ) Independent of Downstream Damage Response (DDR) Pathways
- (2012) Catherine R. Sears et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evidence for base excision repair processing of DNA interstrand crosslinks
- (2012) Anbarasi Kothandapani et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Site-specific DICER and DROSHA RNA products control the DNA-damage response
- (2012) Sofia Francia et al. NATURE
- Prognostic and Predictive Value of a Malignancy-Risk Gene Signature in Early-Stage Non–Small Cell Lung Cancer
- (2011) Dung-Tsa Chen et al. JNCI-Journal of the National Cancer Institute
- A 71-Gene Signature of TRAIL Sensitivity in Cancer Cells
- (2011) J.-J. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell
- (2011) Wei Yu et al. PLoS One
- Secondary mutations of BRCA1/2 and drug resistance
- (2010) Kiranjit K. Dhillon et al. CANCER SCIENCE
- MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer
- (2010) et al. CLINICAL CANCER RESEARCH
- The DNA Damage Response Pathway Regulates the Alternative Splicing of the Apoptotic MediatorBcl-x
- (2010) Lulzim Shkreta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer
- (2010) Chang-Qi Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteomic Dissection of Cell Type-Specific H2AX-Interacting Protein Complex Associated with Hepatocellular Carcinoma
- (2009) Xiaoli Yang et al. JOURNAL OF PROTEOME RESEARCH
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- (2008) Jean-Pierre Pignon et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started